Subscribe To
Alnylam pharmaceuticals' (alny) ceo yvonne greenstreet on q4 2021 results - earnings call transcript
Alnylam pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call Transcript...
February 10, 2022, 12:09 pm
Alnylam pharmaceuticals' (alny) ceo yvonne greenstreet on q4 2021 results - earnings call transcript
Alnylam pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call Transcript...
February 10, 2022, 12:09 pm
Alnylam pharmaceuticals' (alny) ceo yvonne greenstreet on q4 2021 results - earnings call transcript
Alnylam pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call Transcript...
February 10, 2022, 12:09 pm
Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b
Alnylam pharmaceuticals Inc's ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primaril...
February 10, 2022, 12:01 pm
Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b
Alnylam pharmaceuticals Inc's ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primaril...
February 10, 2022, 12:01 pm
Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b
Alnylam pharmaceuticals Inc's ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primaril...
February 10, 2022, 12:01 pm
Is ironwood pharmaceuticals (irwd) a suitable stock for value investors?
Is Ironwood pharmaceuticals (IRWD) a great pick from the value investor's perspective right now? Read o...
February 10, 2022, 10:46 am
Is ironwood pharmaceuticals (irwd) a suitable stock for value investors?
Is Ironwood pharmaceuticals (IRWD) a great pick from the value investor's perspective right now? Read o...
February 10, 2022, 10:46 am
Is ironwood pharmaceuticals (irwd) a suitable stock for value investors?
Is Ironwood pharmaceuticals (IRWD) a great pick from the value investor's perspective right now? Read o...
February 10, 2022, 10:46 am
Is aravive (arav) outperforming other medical stocks this year?
Here is how Aravive (ARAV) and Catalyst pharmaceutical (CPRX) have performed compared to their sector s...
February 10, 2022, 10:46 am
Is aravive (arav) outperforming other medical stocks this year?
Here is how Aravive (ARAV) and Catalyst pharmaceutical (CPRX) have performed compared to their sector s...
February 10, 2022, 10:46 am
Is aravive (arav) outperforming other medical stocks this year?
Here is how Aravive (ARAV) and Catalyst pharmaceutical (CPRX) have performed compared to their sector s...
February 10, 2022, 10:46 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
Nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutica...
February 10, 2022, 8:02 am
Nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutica...
February 10, 2022, 8:02 am
Nkarta to participate at upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutica...
February 10, 2022, 8:02 am
Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical...
February 10, 2022, 8:00 am
Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical...
February 10, 2022, 8:00 am